Company Filing History:
Years Active: 2018
Title: Achim Plum: Innovator in Predictive Medicine
Introduction
Achim Plum is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of predictive medicine, particularly in the treatment of cell proliferative disorders. His innovative work focuses on improving patient outcomes through genetic analysis.
Latest Patents
Achim Plum holds a patent titled "Markers for the prediction of outcome of anthracycline treatment." This invention relates to methods for predicting the effectiveness of anthracycline treatment in patients with cell proliferative disorders. The prediction is achieved by determining the expression levels of specific genes, including PITX2, TFF1, and PLAU. The patent also encompasses sequences, oligonucleotides, and antibodies that can be utilized in these predictive methods. He has 1 patent to his name.
Career Highlights
Throughout his career, Achim Plum has worked with various companies, including Therawis Diagnostics GmbH and Epigenomics AG. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to advancements in medical technology.
Collaborations
Achim has collaborated with notable professionals such as John Foekens and John W Martens. These partnerships have further enriched his research and development efforts in predictive medicine.
Conclusion
Achim Plum's innovative work in predictive medicine highlights the importance of genetic analysis in improving treatment outcomes for patients. His contributions continue to influence the field and pave the way for future advancements.